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Familial exudative v itreoretinopathy (FEVR) is an  inherited blinding disorder of the retinal vascular system. A uto­
somal dom inant FEVR is genetically heterogeneous, b u t its principal locus, E V R 1 , is on chrom osom e I lq l3 -q 2 3 . 
T he gene encoding the W nt receptor frizzled-4 (F Z D 4 ) was recently reported  to  be the E V R 1  gene, b u t our m utation  
screen revealed fewer patients harboring m utations than  expected. H ere, we describe m utations in a second gene 
at the E V R 1  locus, low -density-lipoprotein receptor-related  p ro tein  5 (L R P 5 ), a W nt coreceptor. This finding further 
underlines the significance of W nt signaling in the vascularization of the eye and highlights the poten tia l dangers 
o f using m ultiple families to  refine genetic intervals in  gene-identification studies.
F am ilial exudative  v itre o re tin o p a th y  (FEVR [M IM  
133780J) is a well-defined inherited disorder of retinal 
vessel developm ent (Benson 1995). It is reported  to have 
a penetrance of 100% , but clinical features can be highly 
variable, even w ithin the same family. Severely affected 
patients may be legally blind during the 1st decade of 
life, whereas mildly affected individuals may not even be 
aw are of sym ptom s and may receive a diagnosis only 
by use of fluorescein angiography (O ber et al. 1980). 
The prim ary pathological process in FEVR is believed 
to  be a prem ature arrest of retinal angiogenesis/vascu- 
logenesis or retinal vascular differentiation, leading to 
incomplete vascularization of the peripheral retina (van 
N ouhuys 1991). This failure to vascularize the periph-
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eral retina is the unifying feature seen in all affected 
individuals, but, by itself, it usually causes no clinical 
sym ptom s. The visual problem s in FEVR result from 
secondary com plications due to  the developm ent of hy- 
perperm eable blood vessels, neovascularization, and vi- 
treoretinal traction (fig. 1). These features cause a re­
duction in visual acuity and, in 20%  of cases, can lead 
to  p a rtia l o r to ta l re tinal detachm ent (van N ouhuys 
1991).
FEVR is genetically heterogeneous, w ith  autosom al 
dom inant (Gow and Oliver 1971; Laqua 1980), X-linked 
(Plager et al. 1992; Shastry et al. 1997a), and autosom al 
recessive (Shastry and Trese 1997b; De Crecchio et al. 
1998) modes of inheritance described, w ith  autosom al 
dom inant inheritance being the m ost com m on (M uller et 
al. 1994; Shastry et al. 2000; Kondo et al. 2001). To date, 
two autosom al dom inant loci have been mapped. E V R 1  
on chrom osom e l l q  was the first FEVR locus to  be iden­
tified (Li et al. 1992a), and, subsequently, other groups 
have published further families w ith E V R 1  linkage (Li et 
al. 1992b; M uller et al. 1994; Price et al. 1996; Shastry 
et al. 2000; Kondo et al. 2001), suggesting that m utations
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Figure 1 Clinical appearance of FEVR. Fundus photograph 
shows a fold of retinal tissue due to vitreoretinal traction originating 
from the temporal periphery. This obscures the posterior pole of the 
right eye and therefore compromises the visual acuity.
a t th is  locus a re  a co m m o n  cause  of FEV R . A second  
d o m in a n t locus, EVR3 on  ch ro m o so m e  l i p ,  has  also  
been described in a single large pedigree (D ow ney et al.
2001). A lthough the  gene underlying EVR3 rem ains un ­
identified, th e  gene encoding the W n t recep tor frizzled-4, 
FZD4  (M IM  604579), w as recently repo rted  as the EVR1 
gene (R obita ille  et al. 2002 ).
F ollow ing  the  iden tification  o f FZD4  m u ta tio n s  in p a ­
tien ts w ith  FEV R, w e screened an FEVR p a tien t panel 
o f 40  index  cases for m u ta tio n s  in th is gene. A lthough 
w e d id  find m u ta tio n s , confirm ing  th e  results o f R o b i­
ta ille  e t al. (2 0 0 2 ), these  w ere  iden tified  in on ly  eigh t 
(2 0 % ) pa tien ts  (Toom es et al., in press). A sim ilar low  
n u m b er o f m u ta tio n s w as rep o rted  by R ob itaille  et al. 
(2002), w h o  identified m u ta tio n s  in tw o  (4 0 % ) of the 
five fam ilies they  screened, an d  a recen t study  by K ondo 
et al. (2003) also  identified m u ta tio n s  in only  5 (20% ) 
o f 24  p ro b an d s  screened. T hese results are inconsisten t
w ith  prev ious rep o rts  suggesting  th a t  EVR1 is the  co m ­
m on locus for au to som al d o m in a n t FEVR (M uller et al. 
1994; Price et al. 1996; Shastry  et al. 200 0 ; K ondo  et 
al. 200 1 ). M oreover, o u r screen also  revealed  the  absence 
o f a m u ta tio n  in a fam ily w ith  proven  EVR1 linkage 
(Price e t al. 1996). To investigate th is fam ily further, we 
ana lyzed  th e  linked  h ap lo ty p e  in th e  EVR1 region of 
ch ro m o so m e 1 Iq  13, an d  w e fo u n d  th a t  crossovers re ­
fined the  disease gene in th is fam ily to  an interval of 
~ 1 5  cM  betw een  the m arkers D 11S 1368  an d  D 11S 937 , 
10 cM  cen trom eric  to  FZD4. T hese d a ta  strong ly  sug­
gested  the  presence of a second gene m u ta te d  in FEVR, 
close to  FZD4  an d  w ith in  the  prev iously  defined EVR1 
locus (Toom es e t al. 2004).
D espite the fact th a t >250  genes are located  w ith in  the 
defined interval, the discovery th a t FEVR can be caused 
by m uta tions in the  W n t recep tor F Z D 4 highlighted  p ro ­
teins involved in the W nt-signaling  pa thw ay  as cand ida te 
FEVR genes (for an u p -to -d a te  list o f all the  p ro te ins 
involved in W n t signaling, see the W n t G ene H om epage 
m ain ta ined  by the Roel N usse lab). W e identified LRP5 
(M IM  603506) as one such cand ida te  gene in the  region. 
LRP5 an d  its closely related  hom ologue LRP6 encode 
single-pass transm em brane  receptors th a t p a rtn e r w ith  
m em bers o f the frizzled fam ily of seven-pass tran sm em ­
brane  receptors to  b ind  W n t pro teins, form ing a func­
tional ligand-receptor com plex  th a t activates the canon i­
cal W nt-|S-catenin pa thw ay  (Pinson et al. 2000 ; Tam ai et 
al. 2000; W ehrli e t al. 2000). LRPS consists of 23 exons 
an d  encodes a 1 ,6 1 5 -am in o  acid pro tein . Its ex tracellu lar 
segm ent con tains four dom ains, each com posed  of six 
Y W TD  repeats (which form  a ,8-propeller structure) and  
an epiderm al g row th  fac to r-lik e  dom ain  (Y W TD-EG F 
dom ain). These are follow ed by th ree low -density-lipo- 
pro tein  recep to r-lik e  (I.D L-R -like) ligand-b ind ing  d o ­
m ains (fig. 2). T he specific function o f I.R P5 rem ains u n ­
k now n , b u t loss of this pro tein  causes osteoporosis- 
pseudogliom a syndrom e (O PPG  [M IM  259770]), a re­
cessive d isorder characterized  by very low  bone m ass and  
blindness (G ong et al. 2001). Individuals w ith  O PPG  are
Figure 2 Schematic diagram of the LRP5 protein showing the location of the mutations within the protein domains. The six YWTD 
repeats are shown as a hexagon to represent their /3-propeller structure, whereas the EGF domains are represented as gray blocks.
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prone to developing bone fractures and deform ations and 
can have various eye abnorm alities, including phthisis 
bulbi, retinal detachments, falciform folds, or persistent 
vitreal vasculature (Frontali et al. 1985). D om inant mis­
sense m utations in L R P 5  have also been described in p a ­
tients w ith  high-bone-m ass disorders (high bone mass 
[M IM  601884], endosteal hyperostosis [M IM  144750], 
and osteopetrosis [M IM  607634]) (Boyden et al. 2002; 
Little et al. 2002; Van W esenbeeck et al. 2003). It is 
thought tha t these missense m utations result in the for­
m ation  of a m u tan t LRP5 pro te in  th a t is functionally  
abnorm al (Boyden et al. 2002).
In light of these findings, L R P 5  was a strong candidate 
for involvement in FEVR and was therefore screened in 
the rem aining 32 patients from  our FEVR patient panel. 
Inform ed consent was obtained from  all subjects tested, 
and ethical approval was obtained from  the Leeds 
Teaching H osp ita ls  T rust research  ethics com m ittee. 
We designed prim ers (table 1) and screened all 23 exons 
and flanking intronic sequences by SSCP-heteroduplex 
analysis (SSCP-HA) and direct sequencing, using estab­
lished protocols (Toomes et al. 2001). In to tal, we dis­
covered six L R P 5  m utations not present in control in­
dividuals (figs. 2 and 3) and a further 13 benign sequence 
variants not previously described (table 2).
We first identified a splice-donor m utation  that segre­
gated w ith FEVR in the family w ith E V R 1  linkage in 
w hich F Z D 4  m utations had  been excluded by genetics 
(fig. 3B [family 1]). This m utation is a substitution of the 
second nucleotide of in tron 21, changing the GT splice- 
donor site to GG, c 4 4 8 8 + 2 t^ g . The precise effect of 
this m utation  has not been determ ined in this family, 
since no RNA was available. However, the m ost com ­
m on outcom e of splice-donor m utations is the deletion 
of the preceding exon. This w ould lead to  the deletion 
of exon 21, resulting in a fram eshift after codon 1449, 
followed by 52 incorrect am ino acids and a prem ature 
term ination at codon 1502.
In a second family originating from  the United States, 
w e identified  a 1-bp in se rtio n  in exon  20 , c4119- 
4120insC . This m utation  segregates w ith the disease in 
that family but was also found in two asymptomatic fam i­
ly mem bers (fig. 3B [family 2]). However, neither of these 
individuals had  been exam ined  by fluorescein angiog-
Table 1
LRP5  SSCP-HA Primers
Exona Primer Name 5'->,3/ Sequence Primer Name 5'->,3/ Sequence
Size
(bp)
1 A IF1’ TTCCGCTCCCGCGCGCCCAGCT 1R21’ GCGGGGCCGCCCGGGCCATT 311
2 start 2Fb CAT CCCAGGGCT GT GTAT CT SSCP 2-R GT GAT GACCACGTT CTGCAC 288
2 end SSCP 2-F CAAGCAGACCTACCT GAACC 2Rb ACTT GGGCT CAT GCAAATT C 309
3 start 3F31’ GAAACCATACCT GTT GGTTATTT CC SSCP 3-R GGAT GAAGCT GAGCTT GGCGT C 311
3 end SSCP 3-F CGGATTGAGCGGGCAGGGAT 3R31’ CACAGACCCT GACGCT GTT C 323
4 4F41’ GATGGCTCCTCCACCCCGCT 4R51’ GCGCCCCAGCCGGCACT 250
5 5F31’ CT CATT CAGAAACAAGT GACGGT CCT C 5R41’ GTCCCGTCCCACCGCCT 216
6 start 6F11’ TGGCT GAGTATTT CCCTTGCCC SSCP 6-R GT CGACCGCGAT GCCAT CGG 352
6 end SSCP 6-F CGACCCGCTAGAGGGCTAT GT SSCP 6-2R CAATCTCCCTCTCGCCTGTGC 338
7 7Fb GAT GCT GCAGAGACCAGACA 7R21’ TAACTAi i i i CTCAAGCATTCCATGT 366
8 start 8F11’ T GAAGTT GCTGCT CTT GGGCA SSCP 8-R CACCCGCT CGAT GCT GCGGC 256
8 end SSCP 8-F CGCACAi i i iCGGGTTCACGC 8R11’ AACACTTATGCCCAGGCATGGA 252
9 start 9F11’ TGCTGGGCT GTT GAT GTTTAGACT SSCP 9-R CCGT GAGCGGGAT GGCCACG 263
9 end SSCP 9-F GT GCCT GAGGCCTT CTT GGT CT 9R11’ CTT GAACT GCGTTACAATAAATACGA 291
10 10F11’ GAT GCT GGTT CCTAAAAT GT GG 10R1’ GCT CTAAT CACT GAGGGCCA 386
11 11F11’ GAGGGCT GAGCT GAAGAGGT 11R11’ CAGGTT GGGGAACTT GCAG 398
12 start 12F1’ ATT CAT GT GGT CGCTAGGCT SSCP 12-R CAT CACGAAGT CCAGGT GG 281
12 end SSCP 12-F CTAGCGGCCGGAACCGCA 12R1’ GAAGCTCCTTT CAGCGT CAG 287
13 13F1’ CCAGCT CCT CT GT GGCTTAC 13R1’ T CCT CCCT CT GCTAAGGACA 352
14 SSCP 14-F GT CT CCGCCAGT GCT CAG SSCP 14-R CT GT GAGAGGCT GGCATT C 334
15 SSCP 15-F GT GCT GT CCGAGGAGACGC 15R21’ TTACT GACAAT GAAGGCCGGGT 305
16 16F11’ AAGCT GAGT GT GGGGCAAGTT C SSCP 16-R CCACACAGGAT CTT GCACTGG 361
17 17F1’ CAT GAGTT CT CATTT GGCCC 17R1’ GCCACAGGGACT GT GATTTT 321
18 SSCP 18-F GGCT GCGT GT GAT GTT CT C 18R1’ CAGAGCCCCTACT CCT GT GA 371
19 19F1’ CCAGACCTT GGTT GCT GT G 19R1’ CGT CT CCT CCCCTAAACT CC 269
20 20NF1’ AT GTT GGCCACCT CTTT CT G 20NR1’ CT GCCT CCT CCAGAT CATT C 310
21 2 IF1’ GAGT CT CGT GGGTAGT GGGA SSCP 21-R AGAAAGCAAGCAT GCCT CAGAG 373
22 S22F1’ GGAGGAAGGAAGGAATGCCC 22R1’ GCCCACTAGCACCCAGAATA 272
23 SSCP 23-F CGGAT GT GCCTACCGAAT C SSCP 23-R TTACAGGGGCACAGAGAAGC 347
3 Large exons were amplified in two overlapping segments, designated “start” and “end.” 
b Primer sequences obtained from Gong et al. (2001).
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raphy to exclude a very mild phenotype, so their undi­
agnosed condition was not unexpected (Ober et al. 1980). 
This m utation causes a frameshift resulting in 175 incor­
rect am ino acids after codon 1373, followed by a pre­
m ature term ination at codon 1549 (K1374fsX1549). The 
th ird  m utation  identified was a 1-bp deletion in exon
18, c3804delA , in a single Indian patient. This m utation 
causes a fram eshift resulting in the substitution of 168 
am ino acids after codon 1269 and a prem ature stop in 
codon 1438 (R1270fsX 1438).
The remaining three potential m utations were missense 
changes. In exon 3, we identified T173M  (c518C ^T ) in 
an elderly B ritish w om an  w ith  abnorm al re tina l vas­
cu la tu re  and  re tina l folds. In exon  16, we identified 
Y 1168H  (c3502T^-C) in a British w om an w ith  a total 
retinal detachm ent and retinoschisis. The patient was 
born  after 36 w k of pregnancy but was never treated 
w ith  oxygen therapy. The patient had no family history 
of FEVR, a lthough  the p a tie n t’s asym ptom atic  fa ther 
was also found to have the m utation . The final m utation, 
C1361G  (c4081T^-G), was identified in exon 19 in a 6- 
year-old A ustralian boy w ith  classic features of FEVR. 
This patient has very poor vision and has undergone 
surgery on his left eye, w hich is phthisical and sunken. 
There is no fam ily h isto ry  of FEVR, bu t, again , the 
asym ptom atic m other was found to  have the m utation. 
N either of the asym ptom atic parents had  been exam ined 
by fluorescein angiography, but they showed no signs of 
retinopathy upon fundus exam ination. To exclude the 
possibility that these changes were com m on polym or­
phisms, we screened 200 ethnically m atched control in­
dividuals (400 chrom osom es) for each of these changes 
(Collins and Schwartz 2002). We also checked each of 
the m utated  am ino acids for conservation w ith in  hom o- 
logues of LRP5 from  hum an and other species (fig. 3C). 
Both Y 1168H  and C1361G  are changes to  highly con­
served residues. T 173M  is not well conserved, although 
the m ethionine residue at this position is not seen in any 
FZD4 hom ologue in another species. W hereas these re­
sults suggest th a t these m issense changes are indeed 
pathogenic, w ithout further exam ination by means of a 
functional assay, we are unable  to  prove categorically  
tha t they are disease-causing m utations.
Table 2
Summary of Novel Benign Sequence Variants Detected in LR PS
Location cDNA Change Protein Change Frequency
Exon 2 324C->G V108V C 98%; G 2%
Intron 2 488 + 53t->c t 52%; c 48%
Exon 3 639C->T D213D C 98%; T 2%
Intron 3 686+61c->t c 99%; t 1%
Intron 8 1801+62 c^ t c 99%; t 1%
Intron 11 2503 + 37 c^ t c 99%; t 1%
Intron 11 2503 + 78 g—>a g 52%; a 48%
Exon 18 3918G->A A1306A G 99%; A 1%
Intron 20 4348+13a->g a 99%; g 1%
Exon 21 4380C->T S1460S C 98%; T 2%
Exon 21 4431C->T H1477H C 98%; T 2%
Intron 21 4488+54c->a c 99%; a 1%
Intron 21 4488+58g->a g 98%; a 2%
Exon 22 4574T->C V1525A T 99%; C 1%
N o t e .— Amino acid and nucleotide numbering follows the 
cDNA sequence, with nucleotide position 1 assigned to the first 
nucleotide of the ATG initiation codon in exon 1. Bases in exons 
are denoted by uppercase letters, bases in introns by lowercase 
letters. (NCBI assay ID numbers for these SNPs appear in the 
dbSNP entry of the “Electronic-Database Information” section.)
O n the basis of these results, we propose tha t FEVR 
results from  heterozygous m utations tha t cause haploin- 
sufficiency of LRP5. The insertion, deletion, and splicing 
m utations all lead to  transcripts w ith prem ature term i­
nation, w hich are likely to  be targeted by nonsense-m e­
diated decay. Similar m utations, w hen homozygous, cause 
OPPG. Indeed, c3804delA  has been reported  elsewhere 
as a hom ozygous m utation  in a patient w ith OPPG 
(Gong et al. 2001). It is therefore likely that the missense 
m utations identified also knock ou t the function of 
LRP5. In support of this theory, the C1361G  m utation, 
w hich affects the fifth cysteine w ith in  the th ird  LD L-R - 
like ligand-binding dom ain, is an invariant cysteine re­
qu ired  to  form  a disulfide bond  necessary for correct 
protein folding (Bieri et al. 1995; Fass et al. 1997).
The rem aining tw o missense m utations identified in 
patien ts w ith  FEVR occur w ith in  the first and  fo u rth  
YW TD-EGF domains (fig. 2). To determine the functional 
significance of these m utations, we constructed a model 
of the Y W TD -EG F dom ain  1 of LRP5 based on the
F ig u re  3 FEVR caused by mutations in LRPS. A, Sequence traces of the six mutations identified and the corresponding wild-type alleles. 
The mutation-sequence trace for exon 18 was obtained from a cloned PCR product, so only the disease allele is shown. Other mutations were 
identified from directly sequenced PCR products and therefore appear as heterozygous changes. B, Mutations segregating in two pedigrees with 
FEVR. Unaffected individuals (unblackened); affected individuals (blackened); individuals asymptomatic for FEVR (blackened circle in square). 
Family 1 shows the results of a restriction digest assay through use of HphI, the recognition site of which is abolished by the mutation. The 
arrow indicates the undigested product present in affected individuals. Family 2 shows an SSCP trace (arrow indicates the aberrant shift). In 
family 2, an asterisk (*) indicates individuals affected by low bone mass. C, Protein-sequence alignment of human LRP5 (h) with homologues 
from human and other species: Mus musculus (m), X. laevis (x), Drosophila melanogaster (“arrow”), and Anopheles gambiae str. (“mosquito”). 
(GenBank accession numbers for all species appear in the “Electronic-Database Information” section.) Only 20 amino acid residues surrounding 
each mutation are shown. Conserved amino acid residues are highlighted. The positions of the missense mutations T173M, Y1168H, and 
C1361G are indicated. Both Y1168H and Cl 361G affect highly conserved amino acids, whereas T173M occurs at a less well-conserved residue.
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crystal structure of the YW TD-EGF dom ain of the LDL- 
R (Rudenko et al. 2002). To construct the model, the 
sequences of the four YW TD-EGF dom ains of LRP5 
were aligned w ith  the LDL-R sequence taken from  the 
Protein D ata Bank entry ln 7 d  (chain A), through use 
of the m ultiple-sequence-alignm ent program  ClustalW  
(Chenna et al. 2003) (fig. 4A). The protein hom ology- 
m odeling server Swiss-M odel (Schwede et al. 2003) was 
then used to  construct the model based on this alignm ent 
and the coordinates of the crystal structure of the LDL- 
R YW TD-EGF dom ain ( ln 7 d  chain A) (Rudenko et al.
2002) (fig. 4 B). We used this m odel to  m ap the missense 
m utations found in this study, as well as those missense 
m utations identified in patients w ith  OPPG and high 
bone mass in o ther studies (Gong et al. 2001; Boyden 
et al. 2002; Little et al. 2002; Van W esenbeeck et al.
2003), onto  the three-dim ensional structure of the LRP5 
protein  (fig. 4 B).
M any of the m utations occur in the core of the protein 
and are likely to  cause destabilization of the protein fold. 
This includes the FEVR m uta tion  Y 1168H  from  this 
study and  some of the m utations show n to cause in­
creased bone density (A 242T and T253I) and  OPPG 
(R570W ). The rem aining m utations occur at the protein 
surface (fig. 4 B). It is less clear why m utations at these 
non-sequence-conserved positions (fig. 3C) w ould cause 
destabilization of the fold. However, six of the eight are 
clustered at one location on the protein surface (fig. 4 B). 
It is interesting that all these m utations (T173M  [causing 
FEVR] and D111Y, G171V, G 171R, A214T, and’A214V 
[causing high bone density]) are in the YW TD-EGF d o ­
m ain 1 of LRP5. Furtherm ore, all are in the same region 
tha t corresponds to  the pro tein-protein-binding inter­
face between modules R4 and R5 of the ligand-binding 
dom ain of LDL-R and the (3-propeller dom ain of LDL- 
R (Rudenko et al. 2002). By analogy w ith  LDL-R, it is 
possible tha t the surface region of the YW TD-EGF do­
m ains of LRP5 is also involved in protein-protein inter­
actions and tha t m utating these nonconserved residues 
a t the p ro te in  surface d isrup ts functionally  im p o rtan t 
protein  interactions.
Studies of LRP6 suggest th a t the first and  second 
YW TD-EGF dom ains are required for LRP6 to interact 
functionally w ith  the W nt-frizzled com plex, whereas the 
third and fourth YW TD-EGF repeats are required to  bind 
Dickkopf-1 (Dkk-1), a secreted antagonist of the canoni­
cal W nt-f3-catenin pathw ay (M ao et al. 2001). A more 
recent study in X e n o p u s  has also identified a new LRP6- 
interacting protein know n as “W ise.” D epending on its 
environm ent, Wise can act as both  an activator and an 
inhibitor of W nt signaling and interacts w ith  the first 
and second YW TD-EGF repeats of LRP6, presum ably 
by com peting w ith  the W nt-frizzled com plex (Itasaki et 
al. 2003). The high sim ilarity between LRP5 and LRP6 
suggests that equivalent interactions will occur in LRP5. 
Consistent w ith  this notion, LRP5 has been show n to 
interact w ith  different W nt/frizzled complexes (Tamai et 
al. 2000; Semenov et al. 2001; Kato et al. 2002; Cari- 
casole et al. 2003), although the binding sites have not 
been determ ined. Similarly, LRP5 has been show n to 
interact w ith  Dkk-1 (Bafico et al. 2001; Caricasole et al.
2003), and in vitro  studies have show n tha t the an tag­
onizing effect of Dkk-1 on W nt signaling is alm ost abol­
ished w hen the w ild-type LRP5 protein is replaced w ith 
one harboring the G171V m utation  know n to  cause high 
bone mass (Boyden et al. 2002). Furtherm ore, LRP5 has 
also been reported to interact w ith other members of the 
D ickkopf (Dkk) family of proteins, Dkk-2 and Dkk-3 
(Caricasole et al. 2003), and evidence suggests that these 
p ro teins, like the W ise p ro te in , can  function  as either 
agonists or antagonists, depending on their cellular con­
tex t (Wu et al. 2000 ; M ao  and N iehrs 2003). These 
p relim inary  experim ents indicate th a t com parab le  re­
sults can be obtained for both  LRP5 and LRP6 and 
strengthen the conclusions, based on the m odeling data, 
tha t the missense m utations disrupt a protein-binding 
site.
Expression studies have show n tha t L R P 5  and L R P 6  
are widely expressed in both  em bryonic and adult tis­
sues, including the retina (Brown et al. 1998; Hey et al. 
1998; Kim et al. 1998). However, whereas mice lacking 
Lrp6 show  a w ide range o f developm ental defects in
Figure 4 Homology model of LRP5 YWTD-EGF domain 1. A, ClustalW alignment of the sequence from the YWTD-EGF domain, from 
LDL-R against the four YWTD-EGF domains found in LRP5. Amino acids are numbered in accordance with Swiss-Prot accession number 
P01130 (LDL-R) and GenBank accession number NP_002326 (LRP5). The amino acids highlighted in cyan correspond to the location of the 
T173M and Y1168H missense changes identified in the present study. The residues highlighted in pink correspond to the location of the missense 
mutations shown elsewhere to cause increased bone density (D111Y, G171V, G171R, A214T, A214V, A242T, and T253I) (Boyden et al. 2002; 
Little et al. 2002; Van Wesenbeeck et al. 2003) and OPPG (R570W, R494Q, and V667M) (Gong et al. 2001). The boxes correspond to the 
six YWTD-repeats present in the (3-propeller module. The LDL-R and model LRP5 domain 1 share 37% sequence identity over 310 residues. 
B, Surface representation of the LRP5 YWTD-EGF domain 1. The model is based on the alignment shown in panel A. The location of mutations 
listed in panel A are highlighted on the surface in cyan and pink (numbers correspond to the amino acid residues). The blue backbone ribbon 
represents the ligand-binding domains R4 and R5 of LDL-R and illustrates how these interact with the propeller domain in LDL-R (Rudenko 
et al. 2002). Six of the missense mutations are located on the surface of the LRP5 YWTD-EGF domain 1 structure at a site corresponding to 
the protein-protein interface surface between the R4 and R5 ligand-binding domains and the propeller domain of LDL-R. (Figure prepared 
using GRASP [Nicholls et al. 1991J)
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m ultiple organs (Pinson et al. 2000), mice lacking Lrp5 
have a restricted phenotype. Two groups have indepen­
dently created mice w ith  a targeted d isruption  of Lrp5 
(Kato et al. 2002; Fujino et al. 2003), but it is surprising 
th a t these mice had  different phenotypes. K ato  et al. 
(2002) disrupted Lrp5 at am ino acid 373 (exon 6), and 
im m unohistochem istry showed tha t this allele resulted 
in the form ation of a truncated  polypeptide. The resul­
tan t hom ozygous mice had  low bone mass and persistent 
em bryonic eye vascularization, a phenotype similar to 
tha t observed in patients w ith OPPG. Fujino et al. (2003) 
disrupted Lrp5 at exon 18, but, this time, both immuno- 
blotting and northern  analysis indicated that the hom o­
zygous mice totally lacked Lrp5. These mice appeared 
norm al, w ith  no eye phenotype docum ented and  only a 
very mild low-bone-m ass phenotype, similar to  osteo­
porosis, present in females aged >6 mo. These mice were, 
however, show n to have defects in their cholesterol me­
tabolism  and  glucose-induced insulin secretion (Fujino 
et al. 2003). In both studies, the eyes of the heterozygotes 
appeared norm al, but detailed analysis of the retinal vas­
culature by fluorescein angiography w as no t reported, 
so an  FEVR phenotype cannot be ruled out.
In light of the results of the present study, we w ould 
have expected obligate OPPG carriers to have FEVR; it 
is surprising, therefore, that no eye defects have been re­
ported. This is presum ably a result of the subtle pheno­
type observed in some patients w ith FEVR (O ber et al. 
1980). OPPG carriers have, however, been found to have 
reduced bone mass, w hen com pared w ith  age- and  sex- 
m atched control individuals (Gong et al. 2001). A closer 
inspection of affected m em bers of family 2 w ho had the 
c 4 H 9 _ 4 i2 0 in sC  m utation  showed that they, too, had 
signs of low  bone mass (fig. 3B). Individual 1:2 is os­
teoporotic. H er bone m ineral density (BMD) is 60%  of 
the norm al sex-m atched value and 65%  of the age- and 
sex-m atched value. N o  BMD figures were available for 
o ther affected family m em bers, but their m edical his­
tories highlighted a large num ber of fractures. Individ­
uals 111:2 and 111:3 have had  m ultiple radius and hum erus 
bone fractures since age 6 mo. Individual 111:4 had  a 
radial bone fracture at age 5 years, and individual 1:3 
has had six breaks in to tal (left w rist, right w rist, foot, 
femur, clavicle in tw o places, and right arm ). These re­
sults suggest tha t patients w ith FEVR w ho have L R P S  
m utations show  signs of osteoporosis, a clinical feature 
no t previously noted in FEVR.
The m icroheterogeneity  observed in this study h igh­
lights po ten tia l dangers in using m ultiple families for 
disease-gene refinement and identification. It is possible 
tha t one or both  of these neighboring FEVR genes could 
have been excluded by com bining haplotype data from 
families w ith  m utations in both  F Z D 4  and  L R P S , a w or­
rying scenario for disease gene-m apping projects. Like­
wise, if the genetic analysis in family 1 had no t excluded
F Z D 4  as the m utated  gene in the family, the search for 
their m u ta tio n  w o u ld  have been aban d o n ed , since it 
w ould have been presum ed to  lie outside the coding 
sequence of the gene. As a result, the second m utated 
gene at this locus m ight not have been identified.
In summary, we have show n tha t m utations in either 
L R P S  or F Z D 4 , tw o distinct genes w ith in  the E V R 1  
locus, can cause FEVR. Together, these tw o loci account 
for 35%  of FEVR cases in our patient series (15%  L R P S  
and 20%  F Z D 4), indicating that other unidentified FEVR 
genes may be a m ore significant cause of the disease than 
previously thought. The prim ary pathological process in 
FEVR is believed to  be a p rem atu re  a rrest o f re tina l 
angiogenesis/vasculogenesis or retinal vascular differ­
entiation, leading to incom plete vascularization of the 
peripheral retina. The im plication of tw o com ponents 
of the W nt-signaling pathw ay in this disease process 
highlights the im portance of its role in the developm ent 
of the vascu latu re  o f the eye and , poten tia lly , o ther 
organs.
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